Browse by author
Lookup NU author(s): Professor Ann DalyORCiD, Dr George Rylance
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Protein substitutes are an essential component in the management of phenylketonuria. A series of studies at Birmingham Children's Hospital have investigated their optimal dosage, timing and practical administration as well as the efficacy and tolerance of novel protein substitutes. The key findings are as follows. (1) Lower dosages of protein substitute (1.2 g/kg per day of protein equivalent) adversely affect blood phenylalanine control in children aged 1-10 years. (2) There is wide variability in 24 h blood phenylalanine concentrations. (3) Adjusting protein substitute timing during daytime does not reduce blood phenylalanine variability. (4) Repeated 4 h administration of protein substitute throughout 24 h markedly reduces phenylalanine variability and leads to lower phenylalanine concentrations. (5) The new, concentrated, low-volume protein substitutes and amino acid tablet preparations are efficacious and well tolerated by patients. (6) Administration of protein substitute as a gel or paste has reduced difficulties with administration of protein substitute in children. These findings are important in rationalizing treatment strategies, improving patient compliance and overall in improving blood phenylalanine control. © SSIEM and Kluwer Academic Publishers.
Author(s): MacDonald A, Daly A, Davies P, Asplin D, Hall SK, Rylance G, Chakrapani A
Publication type: Article
Publication status: Published
Journal: Journal of Inherited Metabolic Disease
Year: 2004
Volume: 27
Issue: 3
Pages: 363-371
Print publication date: 01/01/2004
ISSN (print): 0141-8955
ISSN (electronic): 1573-2665
Publisher: Springer
URL: http://dx.doi.org/10.1023/B:BOLI.0000031099.79046.65
DOI: 10.1023/B:BOLI.0000031099.79046.65
PubMed id: 15190194
Altmetrics provided by Altmetric
